2 Breakout biotech stocks to watch today

Two biotech stocks are leading the premarket after reporting positive clinical data from key drug trials.

Good Morning! 

It's Chris from Elite Trade Club, here to give you this morning's premarket trading news.

Let’s get ready to trade!

Markets 📈

The market opened the trading week with a lackluster performance on Monday. Large-cap benchmarks slid, while the Russ2K managed a small gain.

  • Dow [-0.1%]

  • S&P 500 [-0.3%]

  • Nasdaq [-0.1%]

  • Russell 2K [+0.6%]

Futures are edging higher in early trading. S&P 500 contracts are currently up by 0.1%.

What to Watch Today:
Can the market continue its upward trajectory? It appears the recent rally is running into some resistance after getting a big boost from Nvidia’s earnings report last week. Today’s earnings & economy schedule is pretty quiet, so I’ll be watching to see whether the market can break out of its trading range.

This catalyst has happened exactly three times before... on November 28, 2012, July 9, 2016, and May 11, 2020.

And on those three occasions, those who understood what was going on had the chance to collect gains ranging from 8,616%... to 12,280%... all the way up to 330,000%! In just 18 months or less.

Now, trends indicate the next run-up could be right around the corner, and this one could be the biggest one to date.

» Want an Ad-Free Experience? Upgrade Now!

Premarket Highlights 🔎

 👀7 Big Name Stocks to Watch Today

Hold onto your hats, folks, because the stock market is serving up some serious rollercoaster vibes today with these seven bluechip beauties that have everyone talking:

  1. Zoom Video Communications (ZM) 🤳: Zoom's shooting for the stars with a 13% premarket climb, forecasting profits that have investors doing a happy dance. Looks like those endless video meetings aren't ending anytime soon!

  2. Workday (WDAY) 📉: Despite acing profit expectations and hitting revenue targets, Workday is playing it cool with future growth, leaving shares down about 3%. It's like getting an A on your report card but still being grounded.

  3. Hess (HES) 🛢️: Caught in a soap opera with Exxon Mobil and Chevron over a Guyana oil prospect, Hess is the drama queen of the day. Shares are wobbling as Exxon threatens to crash Chevron's buyout party.

  4. Coinbase (COIN)🏅: Riding the crypto wave, Coinbase shares are up 7% premarket, proving that what goes down in the crypto world must come up. Bitcoin's up, so Coinbase is basically the cool kid at the party right now.

  5. Unity Software (U) 💾: Taking a 15% premarket dive, Unity's showing us that even tech giants can have a bad day, with losses bigger than anyone guessed. Time to rally the troops for a comeback?

  6. Lowe's (LOW) 🛠️: Bucking the trend, Lowe's sales might be down, but its earnings are looking up, beating expectations. It's like finding an extra $20 in your winter coat pocket.

  7. Macy’s (M) 📉: Announcing a plan to close 150 stores, Macy's is about 2% down premarket, deciding it's time for a major spring cleaning. Out with the old, in with the new?

So there you have it, the wild ride of today's market watch. Whether you're cheering from the sidelines or biting your nails in anticipation, one thing's for sure: the stock market is never dull!

Featured Earnings 💰️ 

  • American Tower [AMT] ... AM

  • Sempra [SRE] ... AM

  • Constellation Energy [CEG] ... AM

  • American Electric Power [AEP] ... AM

  • Republic Services [RSG] ... PM

  • Agilent Technologies [A] ... PM

  • Extra Space Storage [EXR] ... PM

  • Coupang [CPNG] ... PM

  • Devon Energy [DVN] ... PM

  • Splunk [SPLK] ... PM

Economy 🏗

  • Durable-goods orders [Jan] ... 8:30a

  • S&P Case-Shiller home price index (20 cities) ... 9:00a

  • Consumer confidence [Feb] ... 10:00a

Running Hot 🔥

  • Advent Technologies [ADN] >> +19.9%

  • SoundHound AI [SOUN] >> +22.6%

  • TransMedics [TMDX] >> +14.8%

  • Thoughtworks [TWKS] >> (29.2%)

  • NRX Pharma [NRXP] >> (29.8%)

  • Aaron’s [AAN] >> (22.6%)

Viking Therapeutics [VKTX] - Last Close: $38.48

Small-cap pharma firm Viking Therapeutics is also getting a boost after publishing positive data from a Phase 2 VENTURE Trial of VK2735.

The experimental obesity drug reportedly achieved “significant” weight loss in a mid-stage study.

Viking said the drug was found to be safe & well tolerated. It produced up to 13.1% placebo-adjusted mean weight loss, 14.7% from baseline, in 13 weeks f treatment with no plateau observed.

VKTX is up 80.9% on roughly 4.5 million shares traded thus far.

My Take: VKTX is taking advantage of the weight-loss drug hype generated by Ozempic. This was a mid-stage trial, so Phase 3 studies could provide another catalyst down the road.

Janux Therapeutics [JANX] - Last Close: $15.10

Positive clinical data from two Phase 1a studies is giving this tiny biotech stock a major boost in today’s premarket.

JANX007 and JANX008 produced positive results in clinical trials for metastatic prostate cancer and solid tumors, respectively.

CEO David Campbell said the two drugs produced “encouraging safety and efficacy” data in the trials.

JANX is one of this morning’s top stocks with a 122.0% gain, but volume is a bit light at slightly over 600K.

My Take: JANX stock has been soaring for the past week, and this news just gave it another big boost. I anticipate we’ll see a pullback before the stock settles into a new trading range.

Pubmatic [PUBM] - Last Close: $16.57

A strong after-market earnings release on Monday is fueling a big rally in shares of this micro-cap cloud infrastructure stock.

Pubmatic posted stronger-than-expected earnings, revenues, and forward-looking guidance on its Q4 earnings report.

The company also announced the launch of a $100 million share buyback plan that will run through the end of 2025.

PUBM is up 29.3% on over 100K shares traded.

My Take: PUBM was facing stiff resistance around $18, but this rally has already carried it well past that mark. It could find support at this level if the rally loses steam.

Infobird [IFBD] - Last Close: $2.76

This tiny stock is rebounding from a steep loss on Monday, despite no news to explain the sudden reversal.

Yesterday, Infobird pushed back a previously announced 1-for-8 reverse stock split scheduled for the same day until next week.

The news prompted a 26.9% loss for IFBD on Monday, but it’s dominating the premarket with a 135.0% gain on over 8.5 million shares traded.

My Take: IFBD’s recent upward trend appears to have significant momentum behind it, judging by the sudden reversal.

That's it for today! Thanks for reading, and good luck out there!

Best Regards,

— Chris D.
Elite Trade Club

Text ELITE to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

Join Insider NOW to access
to this report!